DrugDev

What DrugDev does

DrugDev is a cloud-based clinical trial technology company founded in 2008 and headquartered in Wayne, Pennsylvania. The firm operates as a private for-profit business with 251-500 employees and focuses on building solutions that enable better clinical trials for pharmaceutical sponsors, contract research organizations, and investigator sites. Its product surface spans clinical trial operations and financial lifecycle management, with the financial workflow anchored by Stuart Thiede's role as Global Head of Financial Lifecycle.

DrugDev expanded its platform through two targeted acquisitions: CFS Clinical in October 2013, which added clinical trial financial management capabilities, and TrialNetworks in August 2014, which added a networking and collaboration platform for clinical trial sites and sponsors. Leadership is anchored by founder Melissa Easy and Chairman Hugo Stephenson, providing continuity across these inorganic moves. Pricing is not publicly disclosed, consistent with an enterprise SaaS model using quote-based contracts tied to study scope and complexity; the broader source data attributes enterprise field sales, channel partners, and event-driven go-to-market motions to IQVIA rather than DrugDev, so these cannot be directly applied here.

The source material's richness is concentrated on IQVIA's Orchestrated Clinical Trials suite rather than DrugDev itself. Key items such as the IQVIA.ai Platform, NVIDIA partnership (2025-06), Med-R1 8B model, Healthcare-grade AI trademark, and '300+ customers & 1,700+ studies' scale commentary are attributed in the source to IQVIA. Consequently, while DrugDev's broad positioning as a clinical trial SaaS vendor is well supported, specific claims about its current product roadmap, AI features, customer logos, and revenue mix cannot be made without exceeding the evidence in the input.

Name

DrugDev

Website

https://drugdev.com

Company type

Private

Founded year

2008

Headcount range

251–500 employees

Short description

DrugDev is a private cloud-based clinical trial technology company founded in 2008 in Wayne, Pennsylvania, serving pharmaceutical sponsors and investigator sites; it expanded via acquisitions of CFS Clinical (2013) and TrialNetworks (2014).

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Computer Systems Design and Related Services (54151), Other Computer Related Services (541519)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

akta.pro secondary industries

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial technology
• Clinical trial solutions
• Investigator site management
• Clinical research cloud
• Sponsor site platform

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Technology Solutions & Software: Subscription-based technology products including Site Suite, Patient Engagement Suite, Clinical Trial Financial Suite, and Safety Suite. Modular, interoperable technologies for clinical trial management.
2. Clinical Research Services: Functional services and R&D consulting including clinical trial design, execution, and regulatory support across all phases.
3. Real World Evidence & Data: Real-world data sets, analytics, and evidence generation for clinical, regulatory and commercial decision-making.
4. Commercialization Services: Commercial effectiveness solutions including HCP engagement, patient engagement, brand strategy, and launch management.
5. Compliance & Safety Services: Pharmacovigilance, regulatory compliance, quality compliance, and medical information services.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

DrugDev provides cloud-based technology solutions that enable and improve clinical trials for pharmaceutical sponsors, CROs, and investigator sites. The company's offerings support site identification, investigator engagement, and clinical trial financial workflows, with expanded capabilities from the CFS Clinical (investigator payments) and TrialNetworks (site networking) acquisitions.

Product overview

No DrugDev-specific product information found in the provided source data. The source content covers IQVIA's Orchestrated Clinical Trials platform and related technology solutions, but does not contain any information about DrugDev's products or services.

Differentiator

Problem solved

Functional benefit

Products and services

• DrugDev Clinical Trial Cloud Platform Cloud-based technology platform that enables and improves clinical trials for pharmaceutical sponsors, CROs, and investigator sites.
• CFS Clinical Investigator Payments Investigator payment capabilities acquired through CFS Clinical, supporting financial lifecycle management between sponsors/CROs and clinical trial sites.
• TrialNetworks Site Networking Clinical trial site networking solution acquired through TrialNetworks, supporting site engagement and trial collaboration workflows.

Quantifiable outcome

• Faster decision making and reduced risk in clinical development
• +2 more outcomes

Segments8 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• NVIDIAcoreTechnology or Integration · 1 June 2025IQVIA collaborated with NVIDIA to launch AI agents using NVIDIA technology designed to enhance workflows and accelerate insights for life sciences. The custom-built AI agents are specifically designed for the healthcare and life sciences industry to revolutionize workflow automation and enable new workforce capacity.

Scale indicators4 records

Expansion highlights2 records

Broad incumbents

• Parexel International: Parexel is a large CRO with technology-enabled site management and patient recruitment services — competing with IQVIA's/DrugDev's clinical trial site orchestration across pharma outsourcing decisions.
• WCG (WIRB-Copernicus Group): WCG provides IRB services, site training, and clinical research operations technology. Its broader services-and-tech footprint overlaps with DrugDev's site operations and investigator enablement offerings.
• Oracle Health Sciences: Oracle's Clinical One and Siebel CTMS offer end-to-end clinical trial platforms including site management. As a much larger incumbent with broader healthcare/cloud reach, Oracle is a competitor in enterprise site-and-trial contracts.

Direct peers

• Advarra: Advarra provides IRB review, biosafety, and clinical trial site enablement technology (Longboat, CIRBI) — competing with DrugDev's site activation and investigator-facing workflows in site-centric deals.
• Signant Health: Signant Health specializes in clinical trial technology for patient-centric trials including eCOA, eConsent, and site logistics — competing head-to-head with parts of DrugDev's Patient Engagement and Site Suite.
• Veeva Systems: Veeva's Vault CTMS and Vault Site Connect provide clinical trial management and site/investigator collaboration capabilities, directly overlapping with DrugDev's site suite within large pharma customers.
• Clario: Clario (formerly ERT/Bioclinica) provides clinical trial endpoint technology including eCOA, imaging, and site-based respiratory/cardiology solutions — overlapping with DrugDev's patient engagement and site-facing modules.
• Medidata Solutions: Medidata (a Dassault Systèmes subsidiary) provides the Rave clinical trial platform covering EDC, eCOA, RTSM, and site management — directly competing with IQVIA's/DrugDev's site and clinical trial technology suite for pharma R&D budgets.

Emerging players

• Florence Healthcare: Florence Healthcare offers a site connectivity and eISF platform that competes directly with DrugDev's site collaboration tools, with growing adoption among academic medical centers and investigator sites.
• Castor: Castor offers an EDC and decentralized trial platform focused on academic and emerging biopharma sponsors — a more affordable, fast-deploying alternative to DrugDev's enterprise clinical trial suite.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/drugdevinc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DrugDev